Feasibility and preliminary efficacy of R-CHOP-14 in patients with diffuse large B-Cell lymphoma (DLBCL).

被引：0
|
作者：
Halaas, JL [1 ]
Moskowitz, CH [1 ]
Noy, A [1 ]
Portlock, C [1 ]
Horwitz, S [1 ]
Straus, D [1 ]
O'Connor, O [1 ]
Yahalom, J [1 ]
Zelenetz, AD [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6584
引用
收藏
页码：578S / 578S
页数：1
相关论文
共 50 条
  • [31] Effect of atorvastatin versus placebo on efficacy in patients with diffuse large B-cell lymphoma receiving R-CHOP
    Nemec, Ronald
    Scherrer-Crosbie, Marielle
    Abramson, Jeremy S.
    Redd, Robert
    Gilman, Hannah K.
    Ho, Terry
    Wu, Jessica
    Heemelaar, Julius
    Neuberg, Donna
    Hochberg, Ephraim P.
    Barnes, Jeffrey A.
    Armand, Philippe
    Jacobsen, Eric D.
    Jacobson, Caron A.
    Kim, Austin I.
    Friedman, Robb S.
    LaCasce, Ann S.
    Neilan, Tomas G.
    Soumerai, Jacob D.
    LEUKEMIA & LYMPHOMA, 2024, 65 (06) : 783 - 788
  • [32] R-split-CHOP chemotherapy for elderly patients with diffuse large B-cell lymphoma
    Kreher, Stephan
    Lammer, Felicitas
    Augustin, Dieter
    Pezzutto, Antonio
    Baldus, Claudia D.
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2014, 93 (01) : 70 - 76
  • [33] Evolution of R-CHOP therapy for older patients with diffuse large B-cell lymphoma
    Morrison, Vicki A.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2008, 8 (10) : 1651 - 1658
  • [34] Differential Impact of Relative Dose-Intensity Reductions (DIR) in Diffuse Large B-Cell Lymphoma (DLBCL) Treated with R-CHOP21 or R-CHOP14
    Bento, Leyre
    Garcia, Francesc
    Maria Bautista-Gili, Antonia
    Sanchez, Blanca
    Garcia, Lucia
    Gimeno, Eva
    Martinez-Serra, Jordi
    Ferraro, Mariana
    Del Campo, Raquel
    Vercher, Javier
    Scaff, Miguel
    Pacheco, Ana
    Garcia, Florencia
    Ramos, Rafael
    Ballester, Carmen
    Besalduch, Juan
    Bargay, Joan
    Salar, Antonio
    Gutierrez, Antonio
    BLOOD, 2014, 124 (21)
  • [35] Safety and Efficacy of Induction and Maintenance Avelumab Plus R-CHOP in Patients with Diffuse Large B-Cell Lymphoma (DLBCL): Analysis of the Phase II Avr-CHOP Study
    Hawkes, Eliza A.
    Chong, Geoffrey
    Smith, Charmaine
    Lee, Sze-Ting
    Churilov, Leonid
    McKendrick, Joseph
    Renwick, William
    Blombery, Piers
    Nelson, Niles Elizabeth
    Fancourt, Tineke
    Hawking, Joanne
    Lin, Wendi
    Scott, Andrew M.
    Barraclough, Allison
    Wight, Joel
    Grigg, Andrew
    Keane, Colm
    Fong, Chun Yew
    Manos, Kate
    BLOOD, 2020, 136
  • [36] Central nervous system relapse of diffuse large B-cell lymphoma in the rituximab era: results of the UK NCRI R-CHOP-14 versus 21 trial
    Gleeson, M.
    Counsell, N.
    Cunningham, D.
    Chadwick, N.
    Lawrie, A.
    Hawkes, E. A.
    McMillan, A.
    Ardeshna, K. M.
    Jack, A.
    Smith, P.
    Mouncey, P.
    Pocock, C.
    Radford, J. A.
    Davies, J.
    Turner, D.
    Kruger, A.
    Johnson, P.
    Gambell, J.
    Linch, D.
    ANNALS OF ONCOLOGY, 2017, 28 (10) : 2511 - 2516
  • [37] Phase I Trial of Carfilzomib plus R-CHOP (CarR-CHOP) for Frontline Treatment of Patients with Diffuse Large B-Cell Lymphoma (DLBCL)
    Hill, Brian T.
    Dean, Robert M.
    Jagadeesh, Deepa
    Garcia, Alex V. Mejia
    Pohlman, Brad
    Winter, Allison M.
    Krauspe, Ethan
    Collier, Patrick
    D'Andrea, Christopher
    Morrison, Ashley
    Lehmann, Sarah
    Tomlinson, Benjamin K.
    Cooper, Brenda
    de Lima, Marcos
    Ondrejka, Sarah L.
    Hsi, Eric D.
    Caimi, Paolo
    BLOOD, 2018, 132
  • [38] R-Mini-CHOP Versus R-Bendamustine As Primary Treatment for Diffuse Large B-Cell Lymphoma (DLBCL) in Elderly and Comorbid Patients
    Hammersen, Jakob
    Ruethrich, Maria Madeleine
    Kleber, Martina
    Wedding, Ulrich
    Sommer, Michael
    Mueller, Daniela
    Schlattmann, Peter
    Hochhaus, Andreas
    La Rosee, Paul
    BLOOD, 2014, 124 (21)
  • [39] R-CHOP14 compared to R-CHOP21 in elderly patients with diffuse large B-cell lymphoma (DLBCL): Final analysis of the LNH03-6B GELA study.
    Delarue, Richard
    Tilly, Herve
    Salles, Gilles A.
    Thieblemont, Catherine
    Mounier, Nicolas
    Molina, Thierry Jo
    Haioun, Corinne
    Bosly, Andre
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [40] 6 versus 8 cycles of R-chop-14 in elderly patients with DLBCL
    Schubert, J.
    Ziepert, M.
    Lengfelder, E.
    Mohren, M.
    Peter, N.
    Reiser, M.
    Clemens, M.
    Nickenig, C.
    Ho, A. D.
    Eimermacher, H.
    Truemper, L.
    Hoffmann, M.
    Mertelsmann, R.
    Metzner, B.
    Mergenthaler, H.
    Liersch, R.
    Duehrsen, U.
    Balleisen, L.
    Hartmann, F.
    Poeschel, V.
    Schmitz, N.
    Loeffler, M.
    Pfreundschuh, M.
    ANNALS OF ONCOLOGY, 2008, 19 : 148 - 149
12345